ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency

[1]  I. Mohr.  Phosphorylation and dephosphorylation events that regulate viral mRNA translation. , 2006, Virus research.

[2]  T. Kawana.  [Epidemiology of genital herpes]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[3]  P. Kinchington,et al.  Immune control of HSV-1 latency. , 2005, Viral immunology.

[4]  P. Schirmacher,et al.  Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  W. Halford,et al.  Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. , 2005, The Journal of general virology.

[6]  N. Fraser,et al.  Herpes Simplex Virus Type 1 Latency-Associated Transcript Expression Protects Trigeminal Ganglion Neurons from Apoptosis , 2005, Journal of Virology.

[7]  W. Halford,et al.  Mathematical analysis demonstrates that interferons-β and -γ interact in a multiplicative manner to disrupt herpes simplex virus replication , 2005 .

[8]  Mark R. Soboleski,et al.  Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  W. Halford,et al.  Re-Evaluating Natural Resistance to Herpes Simplex Virus Type 1 , 2004, Journal of Virology.

[10]  K. Khanna,et al.  Immune control of herpes simplex virus during latency. , 2004, Current opinion in immunology.

[11]  K. Khanna,et al.  Immunity to latent viral infection: many skirmishes but few fatalities. , 2004, Trends in immunology.

[12]  J. D. Di Santo,et al.  Interplay between Alpha/Beta and Gamma Interferons with B, T, and Natural Killer Cells in the Defense against Herpes Simplex Virus Type 1 , 2004, Journal of Virology.

[13]  R. Everett,et al.  The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes , 2004, Journal of Virology.

[14]  G. Luker,et al.  Bioluminescence Imaging Reveals Systemic Dissemination of Herpes Simplex Virus Type 1 in the Absence of Interferon Receptors , 2003, Journal of Virology.

[15]  I. Mohr,et al.  Regulation of eIF2α Phosphorylation by Different Functions That Act during Discrete Phases in the Herpes Simplex Virus Type 1 Life Cycle , 2003, Journal of Virology.

[16]  P. Pandolfi,et al.  Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects , 2003, Journal of Virology.

[17]  G. Cheng,et al.  Amino acid substitutions in the effector domain of the γ134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-α , 2003 .

[18]  D. Bernstein,et al.  Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. , 2003, The Journal of infectious diseases.

[19]  D. Aaronson,et al.  A Road Map for Those Who Don't Know JAK-STAT , 2002, Science.

[20]  N. DeLuca,et al.  Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection , 2002, Journal of Virology.

[21]  S. Bhattacharya,et al.  Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.

[22]  W. Halford,et al.  The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. , 2002, Virology.

[23]  K. Mossman,et al.  Herpes Simplex Virus ICP0 and ICP34.5 Counteract Distinct Interferon-Induced Barriers to Virus Replication , 2002, Journal of Virology.

[24]  A. Ellison,et al.  Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. L. Thompson,et al.  Herpes Simplex Virus Type 1 Latency-Associated Transcript Gene Promotes Neuronal Survival , 2001, Journal of Virology.

[26]  W. Halford,et al.  ICP0, ICP4, or VP16 Expressed from Adenovirus Vectors Induces Reactivation of Latent Herpes Simplex Virus Type 1 in Primary Cultures of Latently Infected Trigeminal Ganglion Cells , 2001, Journal of Virology.

[27]  W. Halford,et al.  ICP0 Is Required for Efficient Reactivation of Herpes Simplex Virus Type 1 from Neuronal Latency , 2001, Journal of Virology.

[28]  R. Everett.  ICP0, a regulator of herpes simplex virus during lytic and latent infection. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[29]  W. Halford,et al.  Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo , 2000, Journal of Virology.

[30]  R. Silverman,et al.  Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Fink,et al.  Cd8+ T Cells Can Block Herpes Simplex Virus Type 1 (HSV-1) Reactivation from Latency in Sensory Neurons , 2000, The Journal of experimental medicine.

[32]  A. Ellison,et al.  Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. , 2000, Virology.

[33]  A. Nesburn,et al.  Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. , 2000, Science.

[34]  K. Mossman,et al.  Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon , 2000, Journal of Virology.

[35]  H. Virgin,et al.  Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo , 1999, The Journal of experimental medicine.

[36]  R. Everett,et al.  A viral activator of gene expression functions via the ubiquitin–proteasome pathway , 1998, The EMBO journal.

[37]  P. Schaffer,et al.  A Virus with a Mutation in the ICP4-Binding Site in the L/ST Promoter of Herpes Simplex Virus Type 1, but Not a Virus with a Mutation in Open Reading Frame P, Exhibits Cell-Type-Specific Expression of γ134.5 Transcripts and Latency-Associated Transcripts , 1998, Journal of Virology.

[38]  N. DeLuca,et al.  Persistence and Expression of the Herpes Simplex Virus Genome in the Absence of Immediate-Early Proteins , 1998, Journal of Virology.

[39]  P. Pandolfi,et al.  Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.

[40]  P. Speck,et al.  Precipitous clearance of herpes simplex virus antigens from the peripheral nervous systems of experimentally infected C57BL/10 mice. , 1998, The Journal of general virology.

[41]  I. Mohr,et al.  A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. , 1996, The EMBO journal.

[42]  W. Halford,et al.  Quantitative analysis of polymerase chain reaction products by dot blot. , 1996, Analytical biochemistry.

[43]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[44]  S. Jackson,et al.  Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Zinkernagel,et al.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors , 1995, Journal of virology.

[46]  S. Brown,et al.  Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. , 1994, The Journal of general virology.

[47]  W. Gomes,et al.  Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo , 1994, Journal of virology.

[48]  S. Brown,et al.  The herpes simplex virus type 1 strain 17+ γ34.5 deletion mutant 1716 is avirulent in SCID mice , 1994 .

[49]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[50]  S. Deshmane,et al.  A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. , 1994, Virology.

[51]  R. L. Thompson,et al.  ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures , 1994, Journal of virology.

[52]  P. Schaffer,et al.  The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency , 1993, Journal of virology.

[53]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[54]  Siebert Pd,et al.  PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. , 1993 .

[55]  S. Deshmane,et al.  Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice , 1992, Journal of virology.

[56]  T. Block,et al.  The latency-associated transcripts of herpes simplex virus: RNA in search of function. , 1992, Virology.

[57]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[58]  M. Farrell,et al.  Herpes simplex virus latency-associated transcript is a stable intron. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. Schaffer,et al.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA , 1989, Journal of virology.

[60]  P. Schaffer,et al.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture , 1987, Journal of virology.

[61]  E. Wagner,et al.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. , 1987, Science.

[62]  N. DeLuca,et al.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4 , 1985, Journal of virology.

[63]  B. Roizman,et al.  Regulation of Herpesvirus Macromolecular Synthesis I. Cascade Regulation of the Synthesis of Three Groups of Viral Proteins , 1974, Journal of virology.

[64]  G. J. Buddingh,et al.  Studies of the natural history of herpes simplex infections. , 1953, Pediatrics.

[65]  N. Sawtell.  Detection and quantification of the rare latently infected cell undergoing herpes simplex virus transcriptional activation in the nervous system in vivo. , 2005, Methods in molecular biology.

[66]  W. Halford,et al.  Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication. , 2005, Journal of theoretical biology.

[67]  G. Cheng,et al.  Amino acid substitutions in the effector domain of the gamma(1)34.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-alpha. , 2003, Virology.

[68]  L. Morrison.  Vaccines against genital herpes: progress and limitations. , 2002, Drugs.

[69]  C. Preston.  Repression of viral transcription during herpes simplex virus latency. , 2000, The Journal of general virology.

[70]  S. Brown,et al.  The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. , 1994, The Journal of general virology.

[71]  J. Larrick,et al.  PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. , 1993, BioTechniques.